Globeflex Capital’s Integra LifeSciences IART Stock Holding History

Globeflex Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,401	Closed	-$489K	–	495
2020 Q2	$489K	Sell	10,401 -4,886	-32%	-$240K	0.12%	276
2020 Q1	$683K	Sell	15,287 -2,277	-13%	-$119K	0.21%	167
2019 Q4	$1.02M	Hold	17,564	–	–	0.19%	180
2019 Q3	$1.05M	Buy	17,564 +2,064	+13%	+$123K	0.23%	144
2019 Q2	$866K	Sell	15,500 -20	-0.1%	-$1.03K	0.18%	192
2019 Q1	$865K	Hold	15,520	–	–	0.18%	195
2018 Q4	$700K	Hold	15,520	–	–	0.17%	214
2018 Q3	$1.02M	Buy	+15,520	New	+$964K	0.2%	173

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Globeflex Capital's IART Position: Q3 2020 in Review

Globeflex Capital sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 10,401 shares — an estimated $489K sold.

Globeflex Capital first reported a position in IART in Q3 2018 and held it in 8 quarters. The position peaked at $1.05M in Q3 2019. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Globeflex Capital reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
Globeflex Capital sold 10,401 Integra LifeSciences shares in Q3 2020, an estimated $489K.
Globeflex Capital first reported a position in Integra LifeSciences in Q3 2018 and held it in 8 quarters.
Globeflex Capital's Integra LifeSciences position peaked at $1.05M in Q3 2019.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Globeflex Capital's 13F filing for Q3 2020, filed 13 Nov 2020.